ECSP951549A - NEW TREATMENT PROCEDURE - Google Patents
NEW TREATMENT PROCEDUREInfo
- Publication number
- ECSP951549A ECSP951549A ECSP951549A ECSP951549A EC SP951549 A ECSP951549 A EC SP951549A EC SP951549 A ECSP951549 A EC SP951549A EC SP951549 A ECSP951549 A EC SP951549A
- Authority
- EC
- Ecuador
- Prior art keywords
- migraine
- treatment procedure
- new treatment
- headache
- profacial
- Prior art date
Links
- 238000011282 treatment Methods 0.000 title abstract 2
- 206010019233 Headaches Diseases 0.000 abstract 2
- 208000019695 Migraine disease Diseases 0.000 abstract 2
- 206010027599 migraine Diseases 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 206010015943 Eye inflammation Diseases 0.000 abstract 1
- 208000018522 Gastrointestinal disease Diseases 0.000 abstract 1
- 208000010412 Glaucoma Diseases 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 206010043269 Tension headache Diseases 0.000 abstract 1
- 208000008548 Tension-Type Headache Diseases 0.000 abstract 1
- 208000025609 Urogenital disease Diseases 0.000 abstract 1
- 230000000172 allergic effect Effects 0.000 abstract 1
- 206010003246 arthritis Diseases 0.000 abstract 1
- 208000010668 atopic eczema Diseases 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 231100000869 headache Toxicity 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000000414 obstructive effect Effects 0.000 abstract 1
- 208000027232 peripheral nervous system disease Diseases 0.000 abstract 1
- 208000033808 peripheral neuropathy Diseases 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 208000023504 respiratory system disease Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
El invento proporciona el uso de un compuesto la fórmula general en la que R1 y R2 representan de forma independiente H o alquilo de C1-C6 o una de sus sales farmacéuticamente aceptable, para la fabricación de un medicamento para el tratramiento de: trastornos dermatológicos; neuropatias periféricas; artritis; enfermedades gastrointestinales o urogenitales; dolor de cabeza asociado con sustancias o su abandono; dolor de cabeza por tensión; migraña pediatrica; cefalgia disautonómica postraumática; dolor profacial; enfermedades de las vias repiratorias alérgicas u obstructiva crónica; glaucomao inflamación ocular; o profilaxis de la migraña.The invention provides the use of a compound the general formula in which R1 and R2 independently represent H or C1-C6 alkyl or a pharmaceutically acceptable salt thereof, for the manufacture of a medicament for the treatment of: dermatological disorders; peripheral neuropathies; arthritis; gastrointestinal or urogenital diseases; substance-related headache or withdrawal; tension headache; pediatric migraine; post-traumatic dysautonomic cephalgia; profacial pain; chronic allergic or obstructive airway disease; glaucoma or eye inflammation; or prophylaxis of migraine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP951549 ECSP951549A (en) | 1995-10-12 | 1995-10-12 | NEW TREATMENT PROCEDURE |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP951549 ECSP951549A (en) | 1995-10-12 | 1995-10-12 | NEW TREATMENT PROCEDURE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP951549A true ECSP951549A (en) | 1997-05-16 |
Family
ID=42042191
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP951549 ECSP951549A (en) | 1995-10-12 | 1995-10-12 | NEW TREATMENT PROCEDURE |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP951549A (en) |
-
1995
- 1995-10-12 EC ECSP951549 patent/ECSP951549A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200736196A (en) | 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands | |
| UY26782A1 (en) | DERIVATIVES OF BENZOTIAZOLE | |
| UY27300A1 (en) | NEW DERIVATIVES OF QUINOLINA | |
| BR9611015A (en) | Compound, pharmaceutical composition and process for the treatment of an inflammatory disease susceptible to treatment with a non-toxic non-steroidal anti-inflammatory agent, pharmaceutically acceptable salt, use of a compound | |
| BR0212617A (en) | Substituted pyrazolyl compounds for the treatment of inflammation | |
| PT1259489E (en) | AZAPOLICYLIC COMPOUNDS CONDENSED WITH ARYLOUS. | |
| IL160028A (en) | Thiophene carboxamide derivatives, process for their preparation, pharmaceutical compositions comprising them and their use in therapy | |
| FI943948A0 (en) | Heterocyclic carbonic acid derivatives | |
| MXPA04003439A (en) | 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists. | |
| PA8452001A1 (en) | DERIVATIVES OF MACROLIDES C-4 "SUBSTITUTED | |
| MX9702732A (en) | USE OF INDOL DERIVATIVES FOR THE TREATMENT OF DIFFERENT DISEASES. | |
| AR098997A2 (en) | DOSAGE UNIT INCLUDING A PROSTAGLANDINE ANALOG FOR THE CONSTIPATION TREATMENT | |
| CA2454976A1 (en) | Therapeutic agent for glaucoma comprising compound having pi3 kinase inhibitory action as active ingredient | |
| AR034396A1 (en) | COMPOUNDS 4- (1R-4-PIPERIDILEN) -4H-BENZO [4,5] CICLOHEPTA [1,2] -THOPHENE-1-A AND ITS OPTIMALLY ACTIVE ISOMERS, A METHOD FOR SYNTHESIS AND THE USE OF SUCH COMPOUNDS FOR MANUFACTURE OF A MEDICINAL PRODUCT | |
| BR0307905A (en) | benzothiophene and benzofuran derivatives useful in the treatment of hyperproliferative disorders | |
| EP1539136A4 (en) | SELECTIVE COMPOUNDS OF PPAR ALPHA RECEPTORS FOR THE TREATMENT OF DYSLIPIDEMIA AND OTHER LIPID DISORDERS | |
| BR0312780A (en) | Substituted thiophene carboxamide compounds for the treatment of inflammation | |
| AR023687A1 (en) | A COMPOSITION FOR THE TREATMENT OF EXTERNAL RETINA DISORDERS AND THE USE OF A GLUTAMATE ANTAGONIST FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF EXTERNAL RETINA DISORDERS | |
| CA2510514A1 (en) | Alpha-aminoamide derivatives useful as antimigraine agents | |
| ECSP951549A (en) | NEW TREATMENT PROCEDURE | |
| BR0215172A (en) | Benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma | |
| ES2094048T3 (en) | N-ACILPIRROLIDINAS AND MEDICINES FOR THE TREATMENT OR PREVENTION OF DISORDERS RELATED TO CHOLECYSTOCININ AND GASTRINE. | |
| GEP20053512B (en) | S-Methyl-Dihydro-Ziprasidone for Treatment of Psychiatric and Ocular Disorders. | |
| EA200300430A1 (en) | NEW PHARMACEUTICAL COMPOSITIONS CONTAINING EPINASTINES AND PSEVDOEDFEDRIN | |
| AR026242A1 (en) | EMPLOYMENT OF 2-AMINO-3,4-DIHIDRO-QUINAZOLINAS FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OR PROFILAXIS OF DISEASES CAUSED BY CHEMICAL STATES |